Epidarex Capital

1-3 of 3 Articles
Clock icon 3 minutes

University of Edinburgh spin-out Kynos Therapeutics has secured a £9 million investment package led by Epidarex Capital, joined by IP Group and Scottish Enterprise. Kynos has also been awarded £2.5m through an Innovate UK grant to fund a first-time in human Phase 1 clinical trial of its

Clock icon 2 minutes

Edinburgh-based immune-oncology firm Macomics has secured £3.2 million seed funding from Epidarex Capital and the Scottish Investment Bank. Macomics, which is a University of Edinburgh spin-out, will use the proceeds of this fundraising round to develop novel, first-in-class immunotherapies de

1-3 of 3 Articles